Invasive Meningococcal Disease in the Post–COVID-19 Era in South America
Enhanced surveillance of IMD, including genomic characterization of strains, is needed to inform public health policymakers and guide future vaccination strategies in the region.
Authors
- Claudia P. Cortés (ORCID: https://orcid.org/0000-0001-9101-9783)
- Rodolfo Villena (ORCID: https://orcid.org/0000-0001-7829-1387)
- Maria Gabriela Abalos
- Marco Aurélio Palazzi Sáfadi (ORCID: https://orcid.org/0000-0002-4401-9446)
- Ángela Gentile (ORCID: https://orcid.org/0000-0002-1072-7700)
- Alejandro Díaz (ORCID: https://orcid.org/0000-0003-0525-9276)
- Lidia Serra
- Juan Francisco Falconi
Institutions
- Universidad de Santiago de Chile (CL)
- Pfizer (United States) (US)
- Municipality of Medellín (CO)
- Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
- Hospital Pablo Tobon Uribe (CO)
- Hospital General de Niños Ricardo Gutierrez (AR)
- University of Chile (CL)
Publication Details
- Journal
- Vaccines
- Published
- 2025-10-22
- DOI
- https://doi.org/10.3390/vaccines13111079
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer